The DOI matches its Crossref record.
Fatal Phenformin-Associated Lactic Acidosis
Abstract
Letters15 July 1997Fatal Phenformin-Associated Lactic AcidosisJonathan Rosand, MD, Jonathan W. Friedberg, MD, and Jane M. Yang, MDJonathan Rosand, MDMassachusetts General Hospital; Boston. MA 02114, Jonathan W. Friedberg, MDMassachusetts General Hospital; Boston. MA 02114, and Jane M. Yang, MDMassachusetts General Hospital; Boston. MA 02114Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-127-2-199707150-00034 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The popularity of metformin has renewed interest in biguanide hypoglycemic agents. The association between phenformin and fatal lactic acidosis, particularly in patients with renal failure, led to the withdrawal of phenformin from the U.S. market in 1977 [1]. We describe a patient who recently died of phenformin-associated lactic acidosis.A 64-year-old Haitian woman with diabetes, hypertension, and consequent renal insufficiency presented with profound lactic acidosis (pH, 7.15; bicarbonate level <5.0 mmol/L; lactic acid level, 54.5 mmol/L). She had been hospitalized on four previous occasions for unexplained severe lactic acidosis. After recovery from such an episode, muscle biopsy ...References1. Misbin RI. Phenformin-associated lactic acidosis: pathogenesis and treatment. Ann Intern Med. 1977; 87:591-5. Google Scholar2. Reznik-Schuller HM, Reuber MD. Ultrastructure of liver tumors induced in F344 rats by methapyrilene. J Environ Pathol Toxicol Oncol. 1986; 7:181-96. Google Scholar3. Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996; 334:574-9. Google Scholar Author, Article, and Disclosure InformationAffiliations: Massachusetts General Hospital; Boston. MA 02114 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byFrom old to new — Repurposing drugs to target mitochondrial energy metabolism in cancerThe Surprising Effect of Phenformin on Cutaneous Darkening and Characterization of Its Underlying Mechanism by a Forward Chemical Genetics ApproachReview of Biguanide (Metformin) ToxicitySynergistic Anti-Cancer Effect of Phenformin and OxamateMetformin: an old but still the best treatment for type 2 diabetesReview: Metformin: Potential benefits and use in chronic kidney diseaseInsulin, glucagon, and hypoglycemic drugs 15 July 1997Volume 127, Issue 2Page: 170KeywordsAutopsyBicarbonatesDehydrogenasesElectron microscopyHepatocytesLactic acidosisMitochondriaPyruvateRenal failureSodium Issue Published: 15 July 1997 Copyright & PermissionsCopyright © 1997 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several reports in literature related an increased risk of lactic acidosis with biguanides, mostly phenformin, with an event rate of 40–64 per 100,000 patients years [159] whereas the reported incidence with metformin is 6.3 per 100,000 patients years [160].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [159]
Citations
Cited by
Sorted by citations
Metformin: An Old But Still the Best Treatment for Type 2 Diabetes
Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567
Review of Biguanide (Metformin) Toxicity
Wang, G. S., & Hoyte, C. O. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618793385 · Cited by 164
Synergistic Anti-Cancer Effect of Phenformin and Oxamate
Miskimins, W. K., Ahn, H. J., Kim, J. Y., Ryu, S., Jung, Y., & Choi, J. Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085576 · Cited by 144
Review: Metformin: Potential benefits and use in chronic kidney disease
Pilmore, H. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01328.x · Cited by 69
From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
Aminzadeh-Gohari, S., Weber, D. D., Vidali, S., Catalano, L., Kofler, B., & Feichtinger, R. G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.025 · Cited by 34
Novel Mitochondria-targeted Drugs for Cancer Therapy
Fialová, J. L., Raudenská, M., Jakubek, M., Kejík, Z., Pavel Martasek, E., Babula, P., Matkowski, A., Filipenský, P., & Masařík, M. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666201118153242 · Cited by 22
Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients
Rocic, B., Bajuk, N. B., Ročić, P., Weber, D. S., Boras, J., & Lovrenčić, M. V. (2009) · Clinical and investigative medicine · doi:10.25011/cim.v32i6.10669 · Cited by 13
Risk of Suicide in Juvenile Justice Facilities
Gallagher, C. A., & Dobrin, A. (2007) · Criminal Justice and Behavior · doi:10.1177/0093854807302177 · Cited by 7
Kim, B., Lee, J., Shin, J. S., Suh, J.-W., Jung, S., Hwang, G., Lee, H., & Lee, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-02729-7 · Cited by 5
Takano, K., Hachiya, A., Murase, D., Kawasaki, A., Uda, H., Kasamatsu, S., Sugai, Y., Takahashi, Y., Hase, T., Ohuchi, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041451 · Cited by 5
Weighing the Potential Benefits and Risks of Antidiabetic Agents in Older Adults
Neumiller, J. J., Odegard, P. S., & Haines, S. T. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.3.172 · Cited by 1
Insulin, glucagon, and hypoglycemic drugs
Krans, H. M. J. (2003) · Side effects of drugs annual · doi:10.1016/s0378-6080(03)80049-1 · Cited by 1
Insulin, glucagon, and hypoglycemic drugs
Krans, H. M. J. (1999) · Side effects of drugs annual · doi:10.1016/s0378-6080(99)80047-6
Marcucci, F., & Rumio, C. (2026) · Cell Signaling Inflammation & Disease · doi:10.1186/s44505-026-00005-x
Li, X.-D., Shao, L., Huang, J.-M., Li, S.-F., Zhang, Z.-L., Li, M.-C., Zheng, Q., Chen, M., & Huang, W. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124673
Metadata
- Authors
- Rosand, J., Friedberg, J. W., & Yang, J. M.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Rosand, Jonathan
- ORCID
- Rosand, Jonathan
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1997-07-15
- Volume
- 127
- Issue
- 2
- Pages
- 170
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2070961624
- Cited by
- 15
- References
- 0
- Citations by year
- 2026: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- phenformin, lactic acidosis, metformin, renal failure, diabetes mellitus, drug safety, drug withdrawal, mitochondrial bioenergetics, anticancer drug repurposing, drug-induced liver injury, hepatotoxicity, hepatocellular carcinoma, hepatocellular adenoma, recurrent hepatocellular carcinoma, drug repurposing
- MeSH terms
- Acidosis, Lactic, Female, Haiti, Humans, Hypoglycemic Agents, Middle Aged, Phenformin, Fatal Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review